Fertility preservation is an important type of frontier scientific research in the field of reproductive health. The culture of ovarian cortices to i) initiate primordial follicle growth and ii) procure developing follicles for later oocyte maturation is a promising fertility preservation strategy, especially for older women or cancer patients. At present, this goal remains largely unsubstantiated in primates because of the difficulty in attaining relatively large follicles via ovarian cortex culture. To overcome this hurdle, we cultured macaque monkey ovarian cortices with FSH, kit ligand (KL), basic fibroblast growth factor (bFGF), and/or epidermal growth factor (EGF). The various factors and factor combinations promoted primordial follicle development to different extents. Notably, both bFF (bFGF, 100 ng/ml and FSH, 50 ng/ml) and KF (KL, 100 ng/ml and FSH, 50 ng/ml) contributed to the activation of primordial follicles at day 12 (D12) of culture, whereas at D18, the proportions of developing follicles were significantly higher in the bFF and KF groups relative to the other treatment groups, particularly in the bFF group. Estradiol and progesterone production were also highest in the bFF group, and primary follicle diameters were the largest. Up until D24, the bFF group still exhibited the highest proportion of developing follicles. In conclusion, the bFGF-FSH combination promotes nonhuman primate primordial follicle development in vitro, with the optimal experimental window within 18 days. These results provide evidence for the future success of human ovarian cortex culture and the eventual acquisition of mature human follicles or oocytes for fertility restoration.
Introduction
Fertility preservation is a critical frontier research area in the field of reproductive health. Significant advances have recently been made in fertility management, especially for older female subjects who desire later fertility and for young cancer patients. In the latter case, cryopreservation of ovarian tissues before chemoradiotherapy or treatment of estrogen-sensitive tumors, followed by orthotopic or heterotopic implantation after symptom remission, can restore the ovaries and protect reproductive function. Worldwide, more than 30 live births have been reported in cancer patients after transplantation of frozen/thawed ovarian tissues (Gamzatova et al. 2014) . However, in instances of leukemia or other cancers, grafting is associated with a risk of disease recurrence because reintroduction of malignant cells into the cryopreserved ovarian tissue can take place in patients with leukemia (Donnez et al. 2006 , Dolmans et al. 2010 , Rosendahl et al. 2010 . Therefore, to avoid the transfer of malignant cells, ovarian cortex culture ensuing in vitro differentiation of ovarian follicles or immature cumulus-oocyte complexes into mature oocytes is the best and perhaps only realistic option for fertility preservation (Picton et al. 2008) .
We and numerous other research groups have attempted to culture isolated, preantral follicles for several days, with some preliminary success (Telfer et al. 2008 , Amorim et al. 2009 , Xu et al. 2009 , Desai et al. 2010 . Nonetheless, preantral follicles and oocytes are scarce, and preantral follicles can only rarely be isolated in clinical settings, particularly where estrogen-sensitive cancer patients and older subjects are concerned. Thus, ovarian cortex culture and primordial follicle activation are especially necessary to meet the demand for fertility preservation.
Initial attempts to promote primordial follicle development in vitro focused on the growth of isolated follicles. Many investigators clearly showed that it is fairly straightforward to harvest rodent primordial follicles by mechanical means, while in the tougher ovarian cortex of large animals and human beings, primordial follicles must be isolated via mechanical together with enzymatic methods (Greenwald & Moor 1989 , Oktay et al. 1997 , Abir et al. 1999 , Rice et al. 2008 . However, the lack of influence from extrafollicular cortical cells leads to the demise of isolated primordial follicles in vitro. Therefore, in large animals and humans, the in vitro growth and maturation of primordial oocytes are only likely to be initiated in situ by culture of the ovarian cortex. Preantral follicles can then be isolated and grown into the antral stage of folliculogenesis. Accordingly, ovarian cortex culture and primordial follicle activation are both technically necessary for primordial follicle growth and development.
Activation of primordial follicles is modulated through an intricate balance between stimulatory and inhibitory factors (Picton 2001 , Picton et al. 2008 . Hsueh AJ. Laboratory has recently demonstrated fragmentation of ovary-disrupted ovarian Hippo signaling, leading to increased expression of downstream growth factors and promotion of follicle growth. Phosphatidylinositol 3 kinase (PI3K)/AKT pathway allows short-term activation of dormant ovarian follicles in vitro (Li et al. 2010 , Kawamura et al. 2013 . Addition of FSH, epidermal growth factor (EGF), and basic fibroblast growth factor (bFGF) are beneficial for the follicular transition (Matos et al. 2007a ,b, Peng et al. 2010 . Kit ligand (KL)/stem cell factor was one of the first identified factors in the promotion of primordial follicle development (Parrott & Skinner 1999) ; importantly, KL also promotes follicle survival and antral cavity formation of caprine preantral follicles in vitro in the absence of FSH (Lima et al. 2011) .
EGF, for its part, is essential for the maintenance of intraovarian primordial follicle viability in the prepubertal cat, albeit without promoting follicle activation (Fujihara et al. 2014) . Furthermore, EGF and FSH both increase the size of goat primordial follicles by stimulating oocyte growth (Silva et al. 2004) . Contrarily, bFGF initiates the activation of primordial follicles in the rat (Kezele et al. 2002) , and interactions between bFGF and KL effectively induce the primordial-to-primary follicle transition in the rat ovary (Nilsson & Skinner 2004) . Matos et al. (2007a,b,c) showed that bFGF at a concentration of 50 ng/ml not only maintained the morphological integrity of caprine preantral follicles in culture for 5 days, but also stimulated the activation of primordial follicles and the subsequent growth of the activated follicles. FSH at 50 ng/ml functioned in a manner reminiscent of bFGF, as did the combination of FSH and bFGF (i.e., by stimulating the activation as well as the growth of primordial follicles into mature follicles) (Matos et al. 2007a,b,c) . Other investigators similarly found that after 7-day culture of the goat ovarian cortex, FGF-10 upheld preantral follicle morphological integrity and promoted activated follicle growth in vitro . In addition, high doses of bFGF reportedly enhanced follicle development in frozen/thawed ovarian tissues of cancer patients under serum-free conditions, and also in cultured human fetal ovarian tissue (Garor et al. 2009) .
Nevertheless, few reports are available regarding the impact of growth factors and hormone signals on human or nonhuman primate ovarian tissue culture, and the coordination of various growth factors and hormones required for proper follicle development and oocyte maturation in vitro remains challenging. Therefore, this study set out to evaluate the effects of EGF, bFGF, and KL in combination with FSH on the in vitro development of primordial follicles derived from the ovarian cortex of the macaque monkey.
Materials and methods

Ethical approval
This study was approved by the Institutional Review Board of Pecking University Third Hospital (Beijing, China). Acquirement of the macaque ovaries was in accordance with the Guide for Care and Use of Laboratory Animals of Peking University (Beijing, China). The protocol was approved by the Institutional Review Board of Animal Experiments of Peking University Third Hospital.
In vitro culture
Immediately after slaughter, ovaries were collected by laparoscopy from 2-to 3-year-old female macaque monkeys with normal body condition. The ovaries were transported in Leibovitz's L-15 Medium (Invitrogen) supplemented with 1% human serum albumin (LifeGlobal, Guilford, CT, USA), 100 IU/ml penicillin, and 100 mg/ml streptomycin (Invitrogen), and placed on ice for transport to the laboratory within 2 h. The ovaries were washed three times with 0.9% saline supplemented with penicillin and streptomycin. Next, in each replicate, the cortices of eight ovaries were dissected into cortical plate fragments (w3 mm long!3 mm wide!1 mm thick), and 100 fragments were selected for the experiments described below. Four fragments were histologically analyzed as uncultured controls, and the remaining 96 fragments were randomly divided into the wells of a 24-well plate, with a total of six different treatments (four fragments per well, yielding a total of 16 fragments per treatment).
Each well contained 250 ml of culture media, consisting of basic medium (alpha-minimum essential medium (a-MEM) plus 1% human serum albumin, 1% insulin/transferrin/ selenium (5 mg/ml insulin, 5 mg/ml transferrin, and 5 ng/ml selenium, ITS) (Invitrogen), 50 mg/ml 6% ascorbic acid (Sigma-Aldrich), 2 mM L-glutamine, 75 mg/ml penicillin G, and 50 mg/ml streptomycin. In some cases, the medium was further supplemented with 50 ng/ml FSH or FSH plus EGF (75 ng/ml), bFGF (100 ng/ml), and/or KL (100 ng/ml). The concentrations of the growth factors were based on their stimulatory effects in earlier studies (Muruvi et al. 2005 , Matos et al. 2007a ,b, Peng et al. 2010 . The six treatment groups finally employed in this study were as follows: i) a-MEM, ii) FSH, iii) bFF (bFGF and FSH), iv) EF (EGF and FSH), v) KF (KL and FSH), and vi) EbKF (EGF, bFGF, KL, and FSH). The medium was changed every 3 days. Noncultured fragments were fixed in 10% formaldehyde on day 0 (D0), while cultured fragments were fixed in 10% formaldehyde on D6, D12, D18, and D24 post-culture for histological analysis.
Morphological classification and histological analysis of growing follicles
The fixed samples were embedded in paraffin wax, and every 12th serial section (5-mm-thick) was chosen to prevent follicles from being counted twice. Routine hematoxylin and eosin staining was performed for histologic examination under light microscopy. Only normal or healthy follicles (spherical shape, oocyte-bearing, intact theca, regularly distributed granulosa cells) with visible oocyte nuclei were recorded.
Follicular stages were classified into five types based on the descriptions of Fortune (2003) , as follows: i) primordial follicles (containing an oocyte surrounded by a single layer of flattened granulosa cells); ii) primary follicles (containing an oocyte surrounded by a single layer of cuboidal granulosa cells); iii) secondary follicles (containing a growing oocyte surrounded by two to five layers of granulosa cells); iv) preantral follicles (containing six or more layers of granulosa cells, or with a diameter of O120 mm, and without any signs of antrum formation); and v) antral follicles (containing an oocyte surrounded by multiple layers of granulosa cells, and with an antrum). In this study, follicles from groups 2, 3, 4, and 5 were collectively termed developing follicles (Gougeon 1996 , Oktay et al. 1998 , Fortune 2003 . All follicles showing no signs of atresia were counted for each treatment group at D6, D12, D18, and D24. Follicle diameters were measured as the mean of two perpendicular diameters. The results of independent triplicate experiments were presented after Statistical analyses (see below).
Hormone assay
Culture media from all treatment groups at each time point (D6, D12, D18, and D24) were collected and stored at K80 8C until use for the hormone assay. The levels of 17b-estradiol (E 2 ) were measured by using a commercial RIA kit at a commercial laboratory (Chemclin Biotech Co. Ltd, Beijing, China). The sensitivity of the E 2 assay was !3 pg/ml. Progesterone levels were assessed by using an ELIZA kit (Roche Diagnostics GmbH). The sensitivity of the progesterone assay was 0.03 ng/ml.
Statistical analyses
The percentages of follicles at different developmental stages and the follicle diameters were calculated and analyzed by first assessing the normality and homogeneity of the data variance, and then by conducting a two-way ANOVA. Next, a one-way ANOVA was conducted, followed by appropriate post hoc analyses with Tukey's test and the least square difference test. Hormone production levels were analyzed by conducting a repeated measures ANOVA. The values were considered to be 6  510  52  30  5  597  12  150  81  34  13  278  18  35  20  7  0  62  24  47  14  7  0  68  FSH  6  154  12  12  3  181  12  237  165  43  3  448  18  240  72  23  5  340  24  288  88  9  2  387  bFF  6  414  45  23  9  491  12  121  72  12  11  216  18  307  144  56  13  520  24  87  54  11  0  152  EF  6  1022  101  74  20  1217  12  77  55  41  11  184  18  259  36  16  3  314  24  145  65  6  0  216  KF  6  253  67  31  16  367  12  196  172  125  11  504  18  185  50  1  0  236  24  38  12  4  1  55  EbKF  6  417  81  12  3  513  12  152  61  72  10  295  18  203  36  18  5  262  24  104  33  30  0  167 The six experimental groups were as follows: i) a-MEM, ii) FSH, iii) bFF (bFGF and FSH), iv) EF (EGF and FSH), v) KF (KL and FSH), and vi) EbKF (EGF, bFGF, KL, and FSH). a-MEM, a-minimal essential medium; bFGF, basic fibroblast growth factor; EGF, epidermal growth factor; KL, kit ligand. 
Results
Development of follicles in the in vitro-cultured ovarian cortex
The numbers of surviving primordial, primary, secondary, preantral, and antral follicles were counted for the uncultured control at D0 and the various treatment conditions at D6, D12, D18, and D24 (Table 1) . We then used these numbers to calculate the fractions of primordial and developing follicles at each stage of development. Figure 1 shows the effects of a-MEM, FSH, bFF, EF, KF, and EbKF on follicle maturation at D6, D12, D18, and D24. In general, the fraction of primordial follicles in the ovarian cortex sections decreased with each time points of culture, while the fraction of developing follicles increased. At 6 days in culture (D6), the fractions of primordial follicles (w0.80-0.85) and developing follicles (w0.15-0.20) were similar across treatment groups, whereas at D12, the developing follicles increased in number, with the highest fraction observed in the bFF group. After 18 days in culture (D18), the fraction of developing follicles showed significant increases in both the bFF and KF groups relative to the other groups, but was still highest in the bFF group. Up until D24, bFF treatment continued to enhance follicle development compared with the other five groups, although all groups showed attenuated follicle development at D24 vs D18. The addition of the factor EbKF (the combination of bFGF, EGF, KL, and FSH) did not significantly increase the percentage of developing follicles at any time point compared with single factors alone (Fig. 1) . Figure 2 shows the time-dependent actions of a-MEM, FSH, bFF, EF, KF, and EbKF on follicle development. The numbers of developing follicles increased gradually with time in culture from D6 to D18 for all treatment groups, with the highest numbers observed at D18, along with the lowest numbers of primordial follicles. However, in all cases, the percentage of developing follicles decreased at D24 to the levels similar to those observed at D12.
Histological observation of the in vitro-cultured ovarian cortex Figure 3 shows representative histological hematoxylin and eosin-stained images of the ovarian cortex in the a-MEM and bFF groups on D6, D12, and D18 of culture. Every stage of follicle development is illustrated. Normal (healthy) follicles were spherical in shape and contained oocytes surrounded by regular granulosa cells and a circular distribution of theca cells. On the other hand, nearly only primordial follicles were observed in the uncultured control group (i.e., the untreated ovarian cortex at D0). The majority of the follicles in the a-MEM group remained in the primordial stage at D6, with only D0  D6  D12  D18  D24  D6  D12  D18  D24  D6  D12  D18  D24  D6  D12  D18  D24  D6  D12  D18  D24  D6  D12 D18 D24 Figure 2 Time-dependent effects of a-MEM, FSH, bFF, EF, KF, and EbKF on follicle development at D6, D12, D18, and D24. The uncultured control group is denoted by D0. The asterisk (*) indicates that the cultured treatment groups were significantly different from the uncultured control (Ctrl) group. Different lowercase letters (a, b, and c) indicate significant differences between the same treatment on different days of culture (P!0.05 or P!0.01). a few primary follicles discerned. At D12, some of the primordial follicles in the a-MEM group became activated, and developed to the primary or preantral stage. However, developing follicles no longer grow significantly at D18. Contrarily, an obvious tendency toward follicle development was observed in the bFF group, especially from D6 to D18. All groups exhibited decreased numbers of viable follicles and/or increased numbers of degenerated follicles until D24 compared with D18. Degenerated follicles corresponded to follicles with a retracted oocyte or a pyknotic nucleus, and/or those surrounded by disorganized granulosa cells that were detached from the basement membrane (Matos et al. 2007a,b) .
Assessment of hormone production
We next assessed hormone production in the various treatment groups (Fig. 4) . In general, all six treatments increased progesterone production over time in culture, with the highest overall progesterone levels seen at D18. In detail, progesterone levels increased from D6 to D12, with the most progesterone production at D12 in the bFF and KF groups (bFF vs KF group, 50.6 ng/ml vs 48.6 ng/ml). At D18, progesterone production in the bFF group rose to 233.9 ng/ml; this value was significantly higher than that observed in any of the other treatment groups at the same time point. However, progesterone levels markedly decreased from D18 to D24 in the bFF group, and likewise in the FSH, EF, and EbKF groups. Progesterone production remained fairly constant in the a-MEM and KF groups during this time period (Fig. 4A and B) . Similar results were observed for E 2 production. The E 2 level in the bFF group was relatively high at D12, and significantly higher than in any of the other treatment groups at D18. E 2 levels were also higher at D18 in the FSH and KF groups vs the EF and EbKF groups. At D24, Figure 3 Histological examination of the ovarian cortex. Images are shown at 20! magnification for the uncultured control group (Ctrl), the cultured a-MEM group at D6, D12, D18, and D24, and the cultured bFF group at D6, D12, D18, and D24. Different types of follicles were labeled with the following: primordial, primary, secondary, and preantral. Scale bar: 50 mm. the E 2 levels generally decreased to lower levels, which were similar to those observed at D12, except for in the a-MEM and FSH groups. In these two groups, E 2 levels were significantly lower at D24 than at D12 ( Fig. 4C and D) .
Measurement of follicle diameters
Lastly, the diameters of all surviving primordial, primary, and secondary follicles were measured at D6, D12, D18, and D24 (Fig. 5) . No significant differences were observed for primordial follicle diameters within each treatment group across the various time points in culture. However, the diameters of the primordial follicles were significantly larger in the bFF group than in the a-MEM, FSH, and KF groups (PZ0.004, 0.038, and 0.013 respectively; not labeled in the figure) . For the primary follicles, significant differences were generally seen between the D6, D12, D18, and D24 time points, in that the diameters at D24 were significantly smaller than those at D6, D12, and D18 (PZ0.001, !0.001, and 0.001 respectively; not labeled in the figure) . In addition, the primary follicle diameters were clearly larger in the bFF group than in the KF and EbKF groups (PZ0.002 and 0.003 respectively); similar results were obtained for the EF group vs the KF group (PZ0.004). However, no significant differences were discerned among the secondary follicle diameters. implying that EGF and KL cannot augment the actions of bFGF and FSH. Moreover, this study used bFGF at a concentration of 100 ng/ml, although we previously employed the growth factor at 200 ng/ml for in vitro follicle culture. Whether bFGF is more effective at 100 or 200 ng/ml is unknown in future human ovarian cortex culture and will require further comparative experimentation. Regardless, bFGF almost certainly can be selected to enhance primordial follicle activation and growth to the preantral stage in humans as well as macaques.
Our research group also previously demonstrated that bFGF might substantially improve the quality of transplanted murine ovarian tissues by increasing follicle quantity and by promoting neoangiogenesis (Gao et al. 2013) . At D24, the percentage of developing follicles and the levels of progesterone and E 2 were lower or similar to those at D18 and D12 (Figs 1, 2, and 4). These findings might be explained by the fact that after longterm culture of ovarian cortex, some of the follicles develop into large preantral follicles or more advanced premature follicles. These latter follicle types require more complicated culture conditions (e.g., a threedimensional culture system, which we successfully used in an earlier study of preantral follicle growth; Wang et al. 2014) . We also suggest that after 18 days, the preantral follicle should be isolated from the ovarian cortex and cultured independently due to the absence of adequate nutrients and oxygen in the intact cortical tissue. In conclusion, we showed that the combination of bFGF and FSH is sufficient to activate primordial follicle development in the cultured macaque monkey ovarian cortex. The results of this study may provide a foundation for future human ovarian cortex culture to restore fertility in cancer patients and older women, and other subjects with impaired or degenerating follicles. First, our shortterm goals are to obtain preantral or antral human follicles by culturing the human ovarian cortex with bFGF and FSH, and then to isolate the follicles for further maturation in vitro; or alternatively, to attain mature human oocytes for fertility preservation or assisted reproduction.
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